ADIA — Adia Med, Inc.

—
OTC · Materials · Chemicals · CIK 1160420 ·
Last close
$0.12
Market Cap
$11.71M
52W High
$0.28
52W Low
$0.02
ADV30
26,050
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 485,385 282,580 51,829 40,418 744,054 128,115 1,123,835
Mar 2026 176,275 67,577 -151,920 -162,525 776,868 136,716 1,197,067
Dec 2025 63,363 -51,790 -212,439 -219,358 594,826 79,392 852,500
Sep 2025 364,391 211,185 84,396 75,572 776,215 153,870 846,781

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-175,765
Investing CF
$-26,043
Financing CF
$214,824
CapEx
$-22,298
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-16,095,589
Inventory
$140,500
Receivables
$44,635
ST Investments
$6,450
EBIT TTM
$-224,616
Pretax Income TTM
$-265,893
Interest Exp TTM
$41,277
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,172,258
EBITDA
$-207,044
Free Cash Flow
—
Enterprise Value
$13,292,630
Total Cash
$128,115
Total Debt
$993,777
Shares Out
94,404,696
Trailing EPS
$0.00
Book Value
$-0.01
ROE
—
ROA
—
Div Yield
—

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 700,508 -366,492 -395,464 594,826 852,500 -257,674 -179,228
Dec 2024 6,380 -174,749 -181,067 666,181 640,641 25,540 -335,476
Dec 2023 0 0 0 500 1,250 -750 0

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$744,054
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
BIOX Bioceres Crop Solutions Corp. $12.13M $0.19 —
LOOP Loop Industries, Inc. $10.36M $0.21 —
FRTT Fort Technology Inc $10.16M $0.68 —
KARX Karbon-X Corp. $13.89M $0.13 —
BNET BION ENVIRONMENTAL TECHNOLOGIES INC $9.30M $0.16 —

News headlines (Yahoo Finance, 1h cache)

ADIA Med Nearly Doubles Nine-Month Revenue to Surpass $1 Million
2026-11-17 13:00 · Yahoo
Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024
2026-11-09 13:00 · Yahoo
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues
2026-10-26 12:00 · Yahoo
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash
2026-10-20 12:00 · Yahoo
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position
2026-10-13 13:00 · Yahoo
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
2026-10-06 13:20 · Yahoo
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
2026-09-29 12:00 · Yahoo
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
2026-09-22 12:00 · Yahoo
Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment
2026-09-15 12:00 · Yahoo
Nasdaq Shareholder Requirements Just Verified By Adia Med
2026-09-08 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.